Your browser doesn't support javascript.
loading
Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.
Chan, Jason Yongsheng; Lim, Jing Quan; Yeong, Joe; Ravi, Vinod; Guan, Peiyong; Boot, Arnoud; Tay, Timothy Kwang Yong; Selvarajan, Sathiyamoorthy; Md Nasir, Nur Diyana; Loh, Jie Hua; Ong, Choon Kiat; Huang, Dachuan; Tan, Jing; Li, Zhimei; Ng, Cedric Chuan-Young; Tan, Thuan Tong; Masuzawa, Mikio; Sung, Ken Wing-Kin; Farid, Mohamad; Quek, Richard Hong Hui; Tan, Ngian Chye; Teo, Melissa Ching Ching; Rozen, Steven George; Tan, Patrick; Futreal, Andrew; Teh, Bin Tean; Soo, Khee Chee.
Afiliación
  • Chan JY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Lim JQ; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Yeong J; SingHealth Duke-NUS Blood Cancer Centre, Singapore.
  • Ravi V; Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.
  • Guan P; Department of Anatomical Pathology, Singapore General Hospital, Singapore.
  • Boot A; Institute of Molecular and Cell Biology, Singapore.
  • Tay TKY; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Selvarajan S; Integrated Biostatistics and Bioinformatics Programme.
  • Md Nasir ND; Integrated Biostatistics and Bioinformatics Programme.
  • Loh JH; Centre for Computational Biology, and.
  • Ong CK; Department of Anatomical Pathology, Singapore General Hospital, Singapore.
  • Huang D; Department of Anatomical Pathology, Singapore General Hospital, Singapore.
  • Tan J; Department of Anatomical Pathology, Singapore General Hospital, Singapore.
  • Li Z; Department of Anatomical Pathology, Singapore General Hospital, Singapore.
  • Ng CC; Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.
  • Tan TT; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore.
  • Masuzawa M; Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.
  • Sung KW; Laboratory of Cancer Epigenome, Division of Medical Sciences National Cancer Centre Singapore, Singapore.
  • Farid M; Laboratory of Cancer Epigenome, Division of Medical Sciences National Cancer Centre Singapore, Singapore.
  • Quek RHH; Laboratory of Cancer Epigenome, Division of Medical Sciences National Cancer Centre Singapore, Singapore.
  • Tan NC; Department of Infectious Diseases, Singapore General Hospital, Singapore.
  • Teo MCC; Department of Regulation Biochemistry, School of Allied Health Sciences, Kitasato University, Minato City, Tokyo, Japan.
  • Rozen SG; Genome Institute of Singapore, A*STAR, Singapore.
  • Tan P; School of Computing, National University of Singapore, Singapore.
  • Futreal A; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Teh BT; SingHealth Duke-NUS Blood Cancer Centre, Singapore.
  • Soo KC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
J Clin Invest ; 130(11): 5833-5846, 2020 11 02.
Article en En | MEDLINE | ID: mdl-33016928
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hemangiosarcoma / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: J Clin Invest Año: 2020 Tipo del documento: Article País de afiliación: Singapur
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hemangiosarcoma / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: J Clin Invest Año: 2020 Tipo del documento: Article País de afiliación: Singapur